A person on treatment cannot transmit the virus to others
En la región del Bío Bío, Chile, una cifra casi perfecta revela algo más que eficiencia administrativa: revela que una sociedad puede, cuando se lo propone, cerrar la distancia entre el diagnóstico y la dignidad. El 99,7% de las personas con VIH en la región recibe terapia antirretroviral financiada por el Estado, un logro destacado durante la conmemoración del Día de la Vela, que reúne a comunidades para honrar a quienes se han ido y renovar el compromiso con quienes siguen. Lo que queda pendiente no es médico, sino cultural: erradicar el estigma que aún impide que muchos busquen atención a tiempo.
- El Bío Bío alcanza una cobertura antirretroviral del 99,7%, dejando apenas 11 personas sin tratamiento de las 3.466 monitoreadas en el sistema regional de salud.
- La conmemoración del Día de la Vela tensiona entre el logro celebrado y la urgencia de lo que falta: el estigma sigue empujando a personas al silencio y alejándolas del diagnóstico.
- Más de 11.000 pruebas rápidas y 5.138 autotest realizados en 2025 marcan un giro estratégico hacia la detección temprana y la privacidad como herramientas de salud pública.
- A nivel nacional, Chile registra 4.313 nuevos diagnósticos en 2025, cifra estable pero persistente, con el 80,6% en hombres y la mayoría entre los 20 y 39 años.
- Las autoridades sanitarias advierten que el próximo desafío no es farmacológico sino social: transformar la percepción pública sobre las personas que viven con el virus.
En la región del Bío Bío, casi nadie que necesita tratamiento para el VIH se queda sin recibirlo. Los datos preliminares de 2025 muestran que el 99,7% de las 3.466 personas con el virus monitoreadas en centros de salud regionales recibe terapia antirretroviral financiada por el Estado. El logro fue reconocido durante la conmemoración del Día de la Vela, instancia internacional de memoria y renovación del compromiso comunitario frente al VIH.
Este resultado no es casualidad. Es el fruto de un trabajo sostenido entre autoridades sanitarias, instituciones privadas y organizaciones de apoyo a personas que viven con el virus. La terapia antirretroviral —que permite a quienes la reciben llevar una vida larga y saludable— pasó de ser escasa e inaccesible a ser prácticamente universal en esta región.
La conmemoración sirvió también para señalar lo que aún falta. Las autoridades subrayaron tres prioridades: diagnóstico temprano, adherencia al tratamiento y eliminación del estigma. Las tres están entrelazadas: el miedo al juicio aleja a las personas de las pruebas, y la vergüenza dificulta mantener la constancia con los medicamentos.
Para ampliar la detección, durante 2025 se realizaron más de 11.000 pruebas rápidas en la región y se distribuyeron 5.138 autotest, permitiendo que las personas conozcan su estado en privado, sin necesidad de acudir a un centro de salud.
A nivel nacional, Chile registró 4.313 nuevos diagnósticos en 2025, una cifra estable. El 80,6% correspondió a hombres y la mayoría tenía entre 20 y 39 años, lo que señala dónde deben concentrarse los esfuerzos de prevención. Lo que Bío Bío ha demostrado es que la cobertura de tratamiento puede ser casi total. El desafío que sigue es más profundo: cambiar la manera en que la sociedad ve y trata a quienes viven con este virus.
In the Bío Bío region of Chile, nearly every person living with HIV who needs treatment is getting it. The numbers tell a story of a health system that has closed the gap between diagnosis and care: 99.7% of people with the virus in the region are receiving antiretroviral therapy, according to preliminary data from 2025. That translates to 3,455 individuals receiving state-funded treatment out of 3,466 people actively monitored in regional health centers. The achievement was highlighted this week during Candlelight, an international day of remembrance for those lost to AIDS and a moment for communities to recommit to prevention and compassion.
These numbers matter because they represent something that seemed impossible not long ago. Antiretroviral therapy—the combination of drugs that allows people with HIV to live long, healthy lives—was once scarce, expensive, and out of reach for most. Now, in this region at least, it is nearly universal. The gap between those diagnosed and those treated has narrowed to a fraction of a percent. That is not accident. It is the result of deliberate work by public health officials, private institutions, and organizations dedicated to supporting people living with the virus.
The Candlelight commemoration brought those actors together in a shared space. The gathering was designed not just to remember the dead, but to reflect on what remains to be done. Health authorities used the occasion to emphasize three things: the need for early diagnosis, the importance of staying on treatment, and the urgent work of stripping away the stigma that still surrounds HIV. Those three things are not separate. Stigma keeps people from getting tested. Fear of judgment keeps people from seeking care. And people who feel ashamed are less likely to stay consistent with their medications.
The region has also strengthened its ability to find new cases before they become advanced. During 2025, health workers conducted more than 11,000 rapid HIV tests across Bío Bío. In addition, 5,138 people used self-tests—kits they could use in private, at home, removing one more barrier to knowing their status. These numbers suggest a shift toward meeting people where they are, rather than waiting for them to come to clinics.
Nationally, the picture is more mixed. Chile recorded 4,313 new HIV diagnoses in 2025, a figure that has remained relatively stable in recent years. The virus is not disappearing, but neither is it accelerating. The majority of new cases—80.6 percent—occurred in men, while 19.4 percent were in women. Most people diagnosed were between 20 and 39 years old, suggesting that prevention efforts need to reach young adults where they live and work and socialize.
What the Bío Bío region has demonstrated is that treatment coverage can be nearly complete. The harder work now is prevention—keeping people from acquiring the virus in the first place—and the invisible work of changing how communities think about and treat people living with HIV. A person on antiretroviral therapy with an undetectable viral load cannot transmit the virus to others. That scientific fact has not yet fully penetrated public consciousness. Health authorities are clear that the next phase requires not just more tests and more pills, but a fundamental shift in how society sees people living with this condition.
Citações Notáveis
Health authorities emphasized the importance of prevention, access to testing, treatment continuity, and eliminating prejudices associated with HIV— Regional health authority
A Conversa do Hearth Outra perspectiva sobre a história
Why does 99.7% matter? Isn't that just a number?
It matters because it means almost no one is falling through the cracks. In many places, people get diagnosed and then disappear from the system. Here, they're not. The state is reaching them, treating them, keeping them alive.
But the national numbers show 4,313 new diagnoses in 2025. That seems like a lot of people still getting infected.
It is. And that's the point—treatment coverage is nearly perfect, but prevention isn't working the same way. We're good at treating people once they have the virus. We're still struggling to stop transmission before it happens.
The source mentions stigma repeatedly. Is that really a barrier to treatment in 2025?
Absolutely. A person might get tested, learn they're positive, and then avoid the clinic because they're terrified of being seen, of neighbors knowing, of losing their job or their family. Stigma is invisible but it kills. It keeps people from starting treatment, and it keeps them from staying on it.
What does the Candlelight event actually accomplish?
It creates a moment where the community acknowledges that these people exist, that they matter, that they deserve care and dignity. It's a public statement against shame. That sounds small, but for someone afraid to walk into a health center, knowing that their community has gathered to say they belong—that changes things.
The self-tests—5,138 of them—why is that significant?
Because it removes the fear of being seen. You can test at home, alone, and know your status without anyone watching. For people afraid of judgment, that's the difference between knowing and not knowing. And you can't treat what you don't know you have.